Broker Recommendations

JP Morgan raises target price on GSK

By Iain Gilbert

Date: Monday 09 Feb 2026

(Sharecast News) - Analysts at JP Morgan raised their target price on drugmaker GSK to £22.50 on Monday on improving investor perception.
JP Morgan said after GSK's full-year earnings per share came in 2% ahead of consensus and its in-line FY26 constant currency guide, it had opted to trim 26/27E EPS...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page